We have been giving you a lot of follow ups regarding Apple’s new plans and ventures in the past couple of days.
The Vice President of Apple’s health department Dr. Sumbul Desai, operations chief Jeff Williams and Vice President of fitness technologies Jay Blahnik had spoken to TechCrunch’s Darrell Etherington about a possible entry of new health features in the watchOS 9.
One of the most notable features of Apple Watch’s new health features is AFib history. This feature basically allows people that are diagnosed with atrial fibrillation to view an estimate of how often their heart is in this type of arrhythmia.
The company claims that the feature is designed for patients that are 22 years or older and are suffering from atrial fibrillation. Dr. Desai also confirmed that the AFib history feature has received its FDA clearance in the United States after it was legalized in a clinical study.
“As Jeff alluded to, everything we do in health is based on the science, and AFib history was validated in a clinical study, with participants wearing both Apple Watch and an FDA-cleared reference device. In that study, the average difference in weekly measurements between the two devices is actually less than 1%,” said Desai.
On the other hand, Williams added that the AFib history feature will come in handy when a particular patient receives an ablation treatment for chronic atrial fibrillation, however; the treatment gets unsuccessful at the first attempt and the patient continues to experience the atrial fibrillation.
The said feature is not recognized by all countries or regions, therefore; the availability of the feature is going to be limited at its launch. If we start with watchOS 9, it also features a sleep stage tracking that lets you know about the time you spent in REM, core or deep sleep. It also keeps a track of your waking time which is another added advantage.